Palvella Therapeutics (PVLA) PT Raised to $193 at Raymond James
Tweet Send to a Friend
Raymond James analyst Ryan Deschner raised the price target on Palvella Therapeutics (NASDAQ: PVLA) to $193.00 (from $143.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
